Kevin explains why he’s not so bullish on chimeric antigen receptor T-cells (CAR-T cells) for treating cancer.
Welcome to Matt’s first attempt at a minisode. A little rough, I know, but bear with me as I get my ten minute legs under me.
In this minisode I continue the discussion started in epidsode 10 surrounding the goals and rational behind vaccine design in the case of Staphylococcus Aureus. I touch on a paper which proceeded the paper discussed in episode 10, and talk about the data in that paper may cause questions for the potential efficacy of S. aureus humoral vaccination.